Le Lézard
Classified in: Health, Business
Subject: PDT

Moonstone Nutrition Launches New Investment Opportunity on StartEngine to Fuel Company Growth and Prevent Painful Kidney Stones


PITTSBURGH, May 1, 2024 /PRNewswire/ -- Moonstone Nutrition, a pioneering nutraceutical company dedicated to the prevention of kidney stones, is thrilled to announce the launch of its latest investment campaign on StartEngine, one of the leading equity crowdfunding platforms. This exciting initiative offers both seasoned and novice investors the unique opportunity to partake in the growth of a company that's at the forefront of kidney health.

About Moonstone Nutrition

This campaign not only allows individuals to invest in a company with a strong market presence and a proven track record but also to support a worthy cause that impacts millions of lives.

Moonstone Nutrition was founded by leading kidney stone specialists from Harvard, New York University (NYU), and the University of California San Francisco (UCSF). With one in ten Americans suffering from the excruciating pain of kidney stones, and over 2 million annual ER visits, Moonstone's mission has never been more critical. The company's flagship product, Stone Stopper®, is a patented, clinically proven solution that dramatically reduces the incidence of kidney stones. Available in capsules, gummies, and powder drinks, Stone Stopper® effectively increases urine citrate levels and alkalinizes urine, thus preventing the formation of kidney stones. Moonstone Nutrition Stone Stopper® is readily available on major retail platforms like Amazon, Walmart.com, Target.com, and in Walgreens and CVS Health Hub stores.

Investment Opportunity

By investing in Moonstone Nutrition through StartEngine, contributors can directly support and benefit from the company's innovative approach to kidney stone prevention. This campaign not only allows individuals to invest in a company with a strong market presence and a proven track record but also to support a worthy cause that impacts millions of lives.

Why Invest?

Don't miss out on this opportunity to make a tangible difference in the health sector while gaining a stake in a growing company. Invest in Moonstone Nutrition today and be part of a movement that's setting new standards in kidney health. To invest, visit StartEngine here.

For more information, please contact:
Anya Sarkisov
Email: [email protected]
Visit: https://moonstonenutrition.com

Invest today for a healthier tomorrow!

Note: This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security by Moonstone Nutrition or any other third party. Future investment opportunities are subject to change at any time.

SOURCE Moonstone Nutrition


These press releases may also interest you

at 04:00
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2024 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...

at 04:00
Globally, cardiovascular diseases due to atherosclerosis ? the build-up of plaque in arteries ? are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and...

at 03:33
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The Norwegian Hospital Procurement Trust (Sykehusinnkjøp HF)...

at 03:00
One in four people with pre-existing medical conditions (25%) say they will not declare all of their medical conditions when buying travel insurance, with 40% of these only declaring what they are currently being treated for. Of those that would not...

at 03:00
Viewpoint, the esteemed educational program hosted by renowned actor Dennis Quaid, is proud to announce a collaboration with Cedar Community in West Bend, Wisconsin for an upcoming episode that will shed light on the evolving journey of aging. Set to...

at 02:43
Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET. A combined audio cast and telephone conference with the opportunity to ask questions will be...



News published on and distributed by: